Back to top
more

Astrana Health, Inc. (ASTH)

(Delayed Data from NSDQ)

$54.53 USD

54.53
161,652

+0.75 (1.39%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $54.52 -0.01 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 12% (29 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Analysts Estimate Astrana Health, Inc. (ASTH) to Report a Decline in Earnings: What to Look Out for

Astrana Health, Inc. (ASTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EHC vs. ASTH: Which Stock Is the Better Value Option?

EHC vs. ASTH: Which Stock Is the Better Value Option?

Astrana Health, Inc. (ASTH) Q2 Earnings and Revenues Beat Estimates

Astrana Health, Inc. (ASTH) delivered earnings and revenue surprises of 5.26% and 9.58%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

OPCH vs. ASTH: Which Stock Is the Better Value Option?

OPCH vs. ASTH: Which Stock Is the Better Value Option?

Analysts Estimate RadNet (RDNT) to Report a Decline in Earnings: What to Look Out for

RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Astrana Health, Inc. (ASTH) Reports Next Week: Wall Street Expects Earnings Growth

Astrana Health, Inc. (ASTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Amedisys (AMED) Q2 Earnings and Revenues Top Estimates

Amedisys (AMED) delivered earnings and revenue surprises of 8.20% and 2.05%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Here is Why Growth Investors Should Buy Astrana Health, Inc. (ASTH) Now

Astrana Health, Inc. (ASTH) possesses solid growth attributes, which could help it handily outperform the market.

DaVita HealthCare (DVA) Surpasses Q1 Earnings and Revenue Estimates

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 21.43% and 2.01%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Option Care (OPCH) Q1 Earnings and Revenues Surpass Estimates

Option Care (OPCH) delivered earnings and revenue surprises of 18.18% and 4.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Astrana Health Inc. (ASTH) Q4 Earnings and Revenues Top Estimates

Astrana Health Inc. (ASTH) delivered earnings and revenue surprises of 52.94% and 1.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?